Bacterial Vaginosis
Also known as: BV, Vaginal bacteriosis
Bacterial vaginosis (BV) is the most common cause of abnormal vaginal discharge in women of reproductive age. It happens when the protective Lactobacillus bacteria that normally dominate the vagina are replaced by an overgrowth of other bacteria, raising the vaginal pH. The hallmark is a thin, grayish-white discharge with a fishy odor that is often stronger after sex. BV is not classed as a sexually transmitted infection, though sexual activity influences it. It is easily treated with antibiotics but frequently returns. Treating it matters because untreated BV increases the risk of acquiring sexually transmitted infections and of complications in pregnancy.
Last updated November 10, 2026
Understanding Bacterial Vaginosis
Bacterial vaginosis is the most common vaginal condition in women of reproductive age. A US national survey (NHANES) found it in 29 percent of women aged 14 to 49, roughly 21 million at any one time, and 84 percent of them had no symptoms. Prevalence is uneven, about 23 percent in white women, 32 percent in Hispanic women and 51 percent in Black women, differences not explained by behavior and probably reflecting the vaginal bacterial communities people start with. It is not an infection caught from someone in the way chlamydia is, but it is strongly tied to sex: it is rare before first intercourse, more likely with a new partner, and a 2025 trial showed that treating the male partner cuts recurrence. The hallmark is a thin grey discharge with a fishy smell that is worse after sex or during a period, when the vagina becomes less acidic. More than half of women treated with antibiotics have it back within a year.
A healthy vagina is dominated by Lactobacillus, especially L. crispatus, which ferments glycogen from the vaginal lining into lactic acid and holds the pH at 3.8 to 4.5, low enough to suppress most other organisms. In BV, lactobacilli are displaced by a mixed community of anaerobes, Gardnerella vaginalis, Prevotella, Fannyhessea (formerly Atopobium) vaginae, Mobiluncus and others, and the pH rises above 4.5. These bacteria produce amines such as putrescine and trimethylamine, which are odorless when acidic but volatile when the pH rises, so semen and menstrual blood release the smell. Crucially, Gardnerella and its partners form a biofilm on the vaginal lining that antibiotics thin but rarely clear, which is the main reason BV returns: a 12-month study of women treated with oral metronidazole found 58 percent recurred. BV also matters beyond discomfort. It roughly doubles the risk of pelvic inflammatory disease, raises the odds of acquiring HIV by about 60 percent and of acquiring chlamydia, gonorrhea and herpes, and in pregnancy is associated with a 1.5 to 2 fold higher risk of preterm birth. Some episodes resolve on their own, particularly around the mid-cycle estrogen peak.
The CDC's 2021 sexually transmitted infection treatment guidelines recommend oral metronidazole 500 mg twice daily for seven days, metronidazole 0.75 percent vaginal gel once daily for five days, or clindamycin 2 percent cream nightly for seven days; tinidazole, single-dose secnidazole granules and clindamycin ovules are alternatives. These clear symptoms in 70 to 80 percent of women at one month, but about 30 percent recur within three months and over half within a year. For frequent recurrences, the best-studied option is metronidazole gel twice weekly for four to six months, which kept 70 percent of women in remission while on it versus 39 percent on placebo, though many relapsed after stopping; clinicians often add vaginal boric acid 600 mg nightly for 21 days before the maintenance gel, which produced remission in nearly 90 percent at seven weeks in an open study, falling to about half by nine months. The most important recent change is partner treatment: in a 2025 Australian randomized trial of 164 couples, giving the male partner seven days of oral metronidazole plus clindamycin cream to the penis cut recurrence at 12 weeks from 63 to 35 percent, overturning earlier advice that partners need no treatment. An experimental vaginal L. crispatus product (Lactin-V) also reduced recurrence from 45 to 30 percent in a 228-woman trial but is not yet on the market.
Natural approaches are about restoring and keeping lactobacilli after antibiotics, not replacing antibiotics. The honest picture: oral or vaginal Lactobacillus probiotics reduce recurrence in several trials, but the trials are small, use different strains and give mixed results, so the evidence is Moderate at best; a 250 mg vaginal vitamin C tablet (an acidifier, not a nutrient) halved six-month recurrence in a 142-woman trial; vitamin D supplementation helped in one Iranian trial and failed in a US one; and oral garlic tablets were compared with metronidazole in a single small unblinded trial with similar reported results. What does not work, and can hurt: douching with anything, including vinegar, hydrogen peroxide or 'feminine washes', which strips lactobacilli and raises BV risk; inserting garlic cloves, tea tree oil or yogurt, which cause chemical burns and irritation with no proof of benefit; apple cider vinegar baths; and 'pH-balancing' gels without an active acid at a studied dose. Boric acid belongs with the clinician, who should rule out pregnancy and other causes first, because it is toxic if swallowed and should not be used within 24 hours of oral sex.
The most common mistake is to treat the smell with more washing. Odor feels like a hygiene failure, so people douche, use scented washes or wipes, or scrub inside with soap, all of which remove the lactobacilli that keep BV away: douching roughly doubles the odds of BV and is also linked to pelvic inflammatory disease. The second mistake is reaching for an over-the-counter yeast cream, because 'discharge equals thrush'; studies of women self-diagnosing yeast find that only about a third are right, and BV with its thin grey discharge and fishy smell is the commonest thing they actually have. Antifungals do nothing for BV and delay real treatment. What to do instead: wash the vulva with water or a plain unscented soap and put nothing inside the vagina, get a swab or pH test at a clinic or with a reliable home test before treating, and treat a first episode properly rather than symptomatically.
At a Glance
- Common symptoms
- Thin, watery, gray or white vaginal discharge, A fishy odor, often more noticeable after sex or during periods, Mild itching or irritation (less intense than with yeast)
- Main treatments
- Oral metronidazole for several days (avoid alcohol during and shortly after treatment), Metronidazole or clindamycin vaginal gel or cream, Alternative antibiotics such as tinidazole or secnidazole in some cases
- Category
- Reproductive · Very common; the leading cause of vaginal discharge in women of reproductive age
- See a doctor if
- New vaginal discharge with an odor, especially if you have never had it diagnosed
Symptoms
Causes
- Disruption of the normal vaginal bacterial balance
- Overgrowth of anaerobic bacteria such as Gardnerella vaginalis
- Loss of hydrogen-peroxide-producing Lactobacillus species
- Douching, which washes away protective bacteria
- Changes linked to new or multiple sexual partners
Risk Factors
- Douching or using scented washes
- A new sexual partner or multiple partners
- Not using condoms
- Having a copper IUD
- Smoking
- Naturally low levels of Lactobacillus
Diagnosis
- Review of symptoms and sexual and hygiene history
- Pelvic examination to observe the discharge
- Vaginal pH test (BV typically raises it above 4.5)
- Microscopy of a vaginal swab looking for 'clue cells', or a laboratory test
- Screening for sexually transmitted infections when appropriate
Treatment
- Oral metronidazole for several days (avoid alcohol during and shortly after treatment)
- Metronidazole or clindamycin vaginal gel or cream
- Alternative antibiotics such as tinidazole or secnidazole in some cases
- Longer suppressive courses for frequent recurrences
- Supportive: stopping douching and scented products to let normal bacteria recover
- Supportive: consistent condom use, which is associated with fewer recurrences
- Supportive: some evidence suggests certain Lactobacillus probiotics may help prevent recurrence after antibiotics, though results are inconsistent
Natural remedies for bacterial vaginosis: what the evidence says
Ranked by the strength of human evidence for bacterial vaginosis specifically. These sit alongside medical care, not in place of it.
Probiotics (Lactobacillus)
Moderate evidenceThe oral combination of Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 has the most trials: in a Nigerian randomized trial of 125 women, adding it to oral metronidazole raised clearance at 30 days to 88 percent from 40 percent, a result later European trials did not match at that size. A 2009 Cochrane review found too few sound trials to make a recommendation, and a 2020 systematic review of 22 later trials of oral or vaginal lactobacilli concluded they probably reduce recurrence over the months after antibiotics, with low certainty because trials are small and use different strains. Vaginal L. crispatus (Lactin-V) cut 12-week recurrence from 45 to 30 percent in 228 women.
- Studied dose
- Oral L. rhamnosus GR-1 plus L. reuteri RC-14, 1 to 2 billion CFU of each, daily for at least 30 days starting with antibiotics; or a vaginal lactobacillus capsule nightly for 7 to 10 days after treatment.
- Cautions
- Very safe in healthy women; avoid in severe immunosuppression. Generic yogurt or unspecified 'women's probiotics' without these strains have not been tested, and nothing should be inserted vaginally in pregnancy without advice.
Vitamin C (vaginal tablet)
Moderate evidenceThis is a slow-release 250 mg ascorbic acid vaginal tablet that lowers pH, not oral vitamin C. In a 142-woman multicenter trial, inserting it for six days after each period for six months after standard treatment reduced recurrence at six months from 32 to 16 percent. An earlier 277-woman trial found a six-day course alone cleared BV in about 55 percent of women versus 26 percent on placebo. The products are European; in the US a boric acid or lactic acid vaginal suppository is the nearest equivalent, with less trial support.
- Studied dose
- One 250 mg silicone-coated vitamin C vaginal tablet nightly for 6 days for treatment, or for 6 days after each period to prevent recurrence.
- Cautions
- Mild burning or itching in about 5 to 10 percent of users; not studied in pregnancy; it does not replace antibiotics for a symptomatic first episode.
Vitamin D
Preliminary evidenceLow vitamin D is associated with BV in several surveys including NHANES, but supplementation trials conflict: an Iranian trial of about 200 women found 2,000 IU daily for 15 weeks after treatment roughly halved recurrence, while a 2014 US trial of 118 high-risk women given high-dose vitamin D over 24 weeks found no difference in recurrence. The sensible use is to test and correct a deficiency, not to treat BV with it.
- Studied dose
- 1,000 to 2,000 IU vitamin D3 daily if 25-hydroxyvitamin D is below 20 ng/mL; there is no evidence for high doses.
- Cautions
- Safe at these doses; avoid very high dosing without monitoring. Do not expect it to replace antibiotics or probiotics.
Garlic
Preliminary evidenceIn a 2014 Iranian trial, 120 women with BV were randomized to an oral garlic tablet (500 mg twice daily) or oral metronidazole for seven days, with similar clinical improvement reported, but the trial was small, briefly followed up and unblinded, and has not been reproduced in a larger blinded trial. Garlic's allicin kills Gardnerella in the laboratory, which is where the claim comes from.
- Studied dose
- Studied: 500 mg oral garlic tablet twice daily for 7 days. Never inserted vaginally.
- Cautions
- Vaginal garlic causes burns and introduces soil bacteria; oral garlic increases bleeding with warfarin and antiplatelet drugs and should be stopped a week before surgery. It is not a substitute for antibiotics in pregnancy or before a gynecological procedure.
What matters day to day
- Stop douching completely and wash the vulva with water only: douching roughly doubles the odds of BV and nearly a fifth of US women still do it, often to treat the very odor it causes.
- Use condoms consistently, especially with a new partner: in a prospective study, women who used condoms at every act of sex had about 45 percent lower BV incidence, because semen raises vaginal pH and carries partner bacteria.
- Stop smoking: smokers have roughly 1.5 to 2 times the rate of BV, and smoking is linked to lower vaginal lactobacillus levels, independent of sexual behavior.
- Clean shared sex toys between partners and uses, and if your partner is a woman, know that BV is shared between female partners in up to half of couples, so both may need treatment to stop the cycle.
- If choosing contraception, ask about hormonal methods: pooled studies find about 30 percent lower BV rates with estrogen-containing contraception, whereas the copper IUD is associated with a higher rate in the first months.
Prevention
- Do not douche
- Use mild, unscented soap externally only
- Use condoms, particularly with new partners
- Limit the number of sexual partners
- Stop smoking
When to See a Doctor
- New vaginal discharge with an odor, especially if you have never had it diagnosed
- Symptoms persist or return after completing treatment
- You are pregnant and notice abnormal discharge
- Discharge comes with fever, pelvic pain, or pain during sex
- You have had a new partner and could be at risk of a sexually transmitted infection
Frequently Asked Questions
References
- Centers for Disease Control and Prevention. Sexually Transmitted Infections Treatment Guidelines, 2021: Bacterial Vaginosis (2021)
- Vodstrcil LA, Plummer EL, Fairley CK, et al.. Male-partner treatment to prevent recurrence of bacterial vaginosis. New England Journal of Medicine (2025)
- Bradshaw CS, Morton AN, Hocking J, et al.. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. Journal of Infectious Diseases (2006)
- Koumans EH, Sternberg M, Bruce C, et al.. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sexually Transmitted Diseases (2007)
- Cohen CR, Wierzbicki MR, French AL, et al.. Randomized trial of Lactin-V to prevent recurrence of bacterial vaginosis. New England Journal of Medicine (2020)
- Sobel JD, Ferris D, Schwebke J, et al.. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. American Journal of Obstetrics and Gynecology (2006)
- Reichman O, Akins R, Sobel JD. Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis. Sexually Transmitted Diseases (2009)
- Krasnopolsky VN, Prilepskaya VN, Polatti F, et al.. Efficacy of vitamin C vaginal tablets as prophylaxis for recurrent bacterial vaginosis: a randomised, double-blind, placebo-controlled clinical trial. Journal of Clinical Medicine Research (2013)
- Senok AC, Verstraelen H, Temmerman M, Botta GA. Probiotics for the treatment of bacterial vaginosis. Cochrane Database of Systematic Reviews (2009)
- Mayo Clinic Staff. Bacterial vaginosis: symptoms and causes (2024)
Related Conditions
Evidence-graded guides
Lab tests that relate to bacterial vaginosis
Have questions about Bacterial Vaginosis?
Ask Mother Nature AI for personalized, evidence-based guidance.
Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.